Severe autoimmune hemolytic anemia; epidemiology, clinical management, outcomes and knowledge gaps

Autoimmune hemolytic anemia (AIHA) is an acquired hemolytic disorder, mediated by auto-antibodies, and has a variable clinical course ranging from fully compensated low grade hemolysis to severe life-threatening cases. The rarity, heterogeneity and incomplete understanding of severe AIHA complicate...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Femke V. M. Mulder, Dorothea Evers, Masja de Haas, Marjan J. Cruijsen, Sophie J. Bernelot Moens, Wilma Barcellini, Bruno Fattizzo, Josephine M. I. Vos
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Subjects:	autoimmune hemolytic anemia cold agglutinin disease severe mortality management
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1228142/full